Using Gene Editing to Establish a Safeguard System for Pluripotent Stem-Cell-Based Therapies

A major challenge in using human pluripotent stem cells (hPSCs) in therapy is the risk of teratoma formation due to contaminating undifferentiated stem cells. We used CRISPR-Cas9 for in-frame insertion of a suicide gene, iC9, into the endogenous SOX2 locus in human embryonic stem cell (ESC) line H1...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Youjun, Chang, Tammy, Long, Yan, Huang, He, Kandeel, Fouad, Yee, Jiing-Kuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909005/
https://www.ncbi.nlm.nih.gov/pubmed/31821946
http://dx.doi.org/10.1016/j.isci.2019.11.038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909005/
https://www.ncbi.nlm.nih.gov/pubmed/31821946
http://dx.doi.org/10.1016/j.isci.2019.11.038

Ejemplares similares